510(k) Clearance for the eVox System, a non-invasive device that aids diagnosis of cognitive diseasesNEW YORK, NY, USA, January 2, 2018 /EINPresswire.com/ -- Evoke Neuroscience, Inc. announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for the eVox System expanding the Indications for Use to include electroencephalography (EEG) and Event-related Potentials (ERP) that aid physicians in diagnosis.
email us here
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact firstname.lastname@example.org